Udforsk Servier
Servier, grundlagt i 1954, er den første selvstændige farmaceutiske gruppe. Vi har afdelinger i 149 lande med mere end 22.000 ansatte, hvoraf næsten 3.000 er indenfor forskning og udvikling
- 29/07/2020 - Publication of the 2019 CSR Report
- 23/07/2020 - “Coalition Innovation Santé”: Servier supports Chronolife
- 07/07/2020 - Global warming: the Servier strategy validated by the SBTi
- 30/06/2020 - New collaboration between Servier and the Autonomous University of Barcelona in Parkinson’s disease
- 22/06/2020 - “Coalition Innovation Santé”: Servier supports the start-up myCharlotte
- 19/06/2020 - One year anniversary of Servier Paris-Saclay Research Institute’s foundation stone laying
- 15/06/2020 - “Coalition Innovation Santé”: Servier supports the start-up Cureety
- 12/06/2020 - Servier Turkey receives the Best Employer certification
- 10/06/2020 - Counterfeit medicines: A global threat heightened by COVID-19
- 04/06/2020 - Servier completes the acquisition of Symphogen
- 20/05/2020 - Clinical Trials: Servier adapts to ensure continuity
- 19/05/2020 - Global warming: the Servier strategy validated by the SBTi
- 17/05/2020 - Servier is more committed than ever in the fight against hypertension
- 14/05/2020 - Phase 1 Results for ALLO-501 in Non-Hodgkin Lymphoma to be Presented at ASCO
- 06/05/2020 - Covid-19: Mécénat Servier sets up remote skills-based sponsorship missions
- 05/05/2020 - Golden Ticket 2020 awarded to Rgenta Therapeutics, a biotech specializing in diseases considered incurable
- Read more news